Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a

Sandra P Smieszek1, Alyssa R Kaden1, Caroline E Johnson1

  • 1Vanda Pharmaceuticals Inc., Washington, DC, United States.

Frontiers in Neuroscience
|November 30, 2023
PubMed